When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Polidipsia psicogênica

Última revisão: 21 Nov 2024
Última atualização: 28 Sep 2022

Resumo

Definição

História e exame físico

Principais fatores diagnósticos

  • presença de fatores de risco
  • busca e ingestão de água
Detalhes completos

Outros fatores diagnósticos

  • agitação
  • poliúria
  • cefaleia
  • náuseas ou vômitos
  • letargia ou confusão
  • convulsões, delirium ou coma
Detalhes completos

Fatores de risco

  • transtornos psiquiátricos
  • transtornos do neurodesenvolvimento
  • tabagismo
  • abuso de álcool
Detalhes completos

Investigações diagnósticas

Primeiras investigações a serem solicitadas

  • osmolalidade plasmática
  • osmolalidade urinária
  • sódio urinário
  • sódio sérico
  • volume urinário de 24 horas
  • urinálise
  • ureia sérica
  • teste de restrição de água
Detalhes completos

Investigações a serem consideradas

  • teste de vasopressina
  • hormônio antidiurético plasmático
Detalhes completos

Algoritmo de tratamento

Aguda

hiponatremia grave (<125 mmol/L [<125 mEq/L]) ou com sintomas neurológicos

hiponatremia (125-130 mmol/L [125-130 mEq/L]) ou com sintomas gastrointestinais

Contínua

polidipsia crônica

Colaboradores

Autores

Shilpa Srinivasan, MD, DFAPA, DFAAGP
Shilpa Srinivasan

Vice Chair, Medical Staff Affairs, Behavioral Health Midlands, Prisma Health

Professor of Clinical Psychiatry

Program Director: Geriatric Psychiatry Fellowship

Director: Psychiatry Acting Internship and M4 Clerkship

Department of Neuropsychiatry and Behavioral Science

Prisma Health - University of South Carolina School of Medicine Columbia

Columbia

SC

Declarações

SS is a board member of the American Association for Geriatric Psychiatry and serves on the Geriatric Psychiatry Exam Committee for the American Board of Psychiatry and Neurology.

Meera Narasimhan, MD, DFAPA
Meera Narasimhan

Professor and Chair

Department of Neuropsychiatry and Behavioral Science

Senior Medical Director

Prisma Health

Special Advisor to University of South Carolina President

Health Innovations and Economic Development

University of South Carolina School of Medicine Columbia

Columbia

SC

Declarações

MN is a member of an advisory board for Alkermes.

Agradecimentos

Dr Shilpa Srinivasan and Dr Meera Narasimhan would like to gratefully acknowledge Dr Emily Williams and Dr Brian Dundas, previous contributors to this topic.

Declarações

EW declares that she has no competing interests. BD is an author of one of the references for this topic.

Revisores

Branimir Margetić, MD

Neuropsychiatric Hospital "Dr Ivan Barbot"

Popovaca

Croatia

Declarações

BM is an author of a reference cited in this topic.

Aaron Pinkhasov, MD, DFAPA, FACLP

Chairman

Department Of Psychiatry

NYU Langone Hospital

Professor of Psychiatry and Medicine

NYU Long Island School of Medicine

Long Island

NY

Declarações

AP declares that he has no competing interests.

Richard C Millson, MD, DTM&H, FRCPC

Associate Professor of Psychiatry

Queen's University

Kingston

Ontario

Canada

Declarações

RCM declares that he has no competing interests. He is the author of some of the references cited in this topic.

O uso deste conteúdo está sujeito ao nosso aviso legal